Harvard Medical School

New Supercooling Method Triples Organs Viability for Transplant | 9/14/2019

… can stay viable for transplantation for a couple of hours max. But now, you can expand this time window for more than a whole day thanks to the work of a research team from Massachusetts General Hospital (Mass General) and Harvard Medical School (HMS). Supercooling Way to Extend Donor Organs Shelf Life We need better organ storage protocols than the existing cooling and perfusion processes that can’t keep organs viable …

Akouos Launches Sing Registry to Track Genetic Changes in Hearing, Treatments | 9/14/2019

Akouos Launches Sing Registry to Track Genetic Changes in Hearing, Treatments 13, 2019 Akouos , a precision genetic medicine company developing gene therapies to restore and preserve hearing, announced the launch of The Sing Registry: the Genetic Sensorineural Hearing Loss Registry . The Sing Registry is a new, observational research study focused on understanding the lifelong impact of genetic sensorineural hearing loss (SNHL), according to the company. The Sing Registry is sponsored …

Follow Harvard Medical School:    

Beth Israel, Dana-Farber leaders offer a prescription for better digital health: Actionable data at the point of care | FierceHealthcare | 9/13/2019

BOSTON—With an all-time high $14.6 billion in funding going toward digital health startups globally last year, investors are betting big on the promise of tech to address major healthcare challenges and disrupt the industry. Are these digital solutions delivering? They could be doing more, according to John Halamka, M.D., chief information officer at Beth Israel Deaconess Medical Center and professor of medicine at Harvard Medical School. Free Daily …

Americans take aspirin for CVD prevention despite recommendations against it | 9/13/2019

… adults, nearly half of those aged 70 years and older without CVD said they used aspirin. In the overall patient sample, 22.8% reported doing so without their physician’s recommendation. Christina Wee, MD, MPH, of Harvard Medical School and lead author of the study, said that given the recent change in guidelines and new evidence that the benefits of aspirin might be lower than previously thought, the researchers wanted to estimate …

Top NYC Orthopedic Hip Surgeon, Dr. Roy Davidovitch, To Speak At ISTA 32nd Annual Congress | PRWeb | 9/13/2019

Top NYC Orthopedic Hip Surgeon, Dr. Roy Davidovitch, To Speak At ISTA 32nd Annual Congress Share Article Dr. Roy Davidovitch, a top Manhattan, New York orthopedic hip surgeon has been invited to speak at the prestigious International Society for Technology in Arthroplasty (ISTA) 32nd Annual Congress, October 2-5, 2019 in Toronto, Canada. Dr. Davidovitch will be speaking on” Opioid Sparing Protocols for THA to Reduce the Need for Opiates”. Roy …

Presymptomatic Serum Neurofilament Light Chain Levels Before Multiple Sclerosis | 9/13/2019

September 13, 2019 Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis Author Affiliations Article Information 1 Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts 2 Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland 3 Partners Multiple Sclerosis Center, Brigham and Women’s Hospital, Boston, Massachusetts 4 Department of Neurology, Harvard Medical School …

Akouos Launches The Sing Registry to Inform Future Therapeutic Development for Genetic Sensorineural Hearing Loss | Business Wire | 9/13/2019

BOSTON- Akouos , a precision genetic medicine company developing gene therapies to restore and preserve hearing, today announced the launch of The Sing Registry: the Genetic Sensorineural Hearing Loss Registry . The Sing Registry is a new, observational research study focused on understanding the life-long impact of genetic sensorineural hearing loss (SNHL). The Sing Registry is sponsored by Akouos, with plans to create a consortium that builds upon the foundational research …

Medicare-for-all is not Medicare, and not really for all. So what does it actually mean? | 9/13/2019

… if Medicare-for-all, the slogan that has dominated early campaigning in the 2020 Democratic primary, was the solution to his and America’s health care woes. He mumbled something about being too young for Medicare and laid bare the disconnect between how voters think and talk about health care and how candidates do. As the Democratic primary campaign heats up, with the third debate on Sept. 12, candidates have used …

‘Supercool’ method triples organ survival | 9/13/2019

… day, which researchers say could revolutionise organ transplants. The next step will be assessing how long supercooled organs function in large animals such as pigs, before moving to human clinical trials. The team at Massachusetts General Hospital and Harvard Medical School pioneered the technology in rats five years ago. The animal’s tiny livers were chilled while nutrients and oxygen were pumped through the organ’s blood vessels. However, there were challenges …

Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer | 9/13/2019

Translational Cancer Mechanisms and Therapy Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer Sophia C. Kamran , Jochen K. Lennerz , Claire A. Margolis , David Liu , Brendan Reardon , Stephanie A. Wankowicz , Emily E. Van Seventer , Adam Tracy , Jennifer Y. Wo , Scott L. Carter , Henning Willers , Ryan B. Corcoran , Theodore S. Hong and Eliezer M. Van Allen Sophia C. Kamran Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School …

Massachusetts General Hospital creates Lancer Endowed Chair of Dermatology | 9/13/2019

… manage your alerts . Harold Lancer, MD, announced the Lancer Endowed Chair of Dermatology at Massachusetts General Hospital, which will recognize the talent, accomplishments and work of Richard Rox Anderson, MD, FAAD, director of the Massachusetts General Hospital Wellman Center for Photomedicine, as its first recipient. The newly created endowed chair will allow for further research into diagnostic and therapeutic techniques and procedures, according to a press release. Lancer is an …

Sub-zero supercooling technique can help transplant organs survive for longer - AIVAnet | 9/13/2019

Due to the brief period of time a human organ can be kept alive outside the body, organ transplants are a race against the clock. All kinds of different transportation methods have been explored to get organs to the patients who need them, most notably including a world-first, life-saving kidney delivered by drone earlier this year. At Harvard Medical School, researchers have come up with a different approach …

^^Download_[Epub]^^@@ Say Good Night to Insomnia The Six-Week, Drug-Free Program Developed At Harvard Medical School book ‘Full_[Pages]’ 459 | 9/13/2019

Say Good Night to Insomnia The Six-Week, Drug-Free Program Developed At Harvard Medical School book Download at = https://ebooklibraryastri7u83i.blogspot.com/0805089586 Say Good Night to Insomnia The Six-Week, Drug-Free Program Developed At Harvard Medical School book pdf download, Say Good Night to Insomnia The Six-Week, Drug-Free Program Developed At Harvard Medical School book audiobook download, Say Good Night to Insomnia The Six-Week, Drug-Free …

The U=U Message Isn’t Spreading Fast Enough | 9/13/2019

… undetectable levels. “Providers caring for patients with HIV should universally inform their patients about U=U as part of their routine care,” Dr. Sarah Calabrese of George Washington University and Kenneth Mayer of the Harvard Medical School and Fenway Institute write in The Lancet HIV. “Conveying benefits and risks surrounding any treatment is fundamental to patients’ decision-making, and this HIV treatment benefit should be no exception.” Calabrese and Mayer’s …

NEWSMAKER: Dr. Rudolph Tanzi, rock star scientist | 9/13/2019

… KNOW: He played keyboard on Aerosmith’s 2012 album “Music from Another Dimension” and recorded an album with Aerosmith guitarist Joe Perry and actor Johnny Depp. HIS STORY: A quiet corner office in the Harvard Medical Research building in Charlestown is decorated with accolades to Dr. Rudolph “Rudy” Tanzi. The wall is lined with awards for his scientific discoveries, his various academic degrees and a key to his native city of …

What Leads to Academic Corruption? | 9/13/2019

… and I’m not saying all of this is bad, I’m just saying, let’s just understand what’s going on. At one extreme in the medical school, the vast majority of professors of medicine at the Harvard Medical School are not paid by Harvard. Their salary comes from someone else. Lawrence Lessig: So they raise their salaries. So they raise their salary sometimes from the NHS, sometimes, I’m sorry, NIH in America …

Studies highlight work-life imbalance, wage gap for female pediatricians | 9/13/2019

Studies highlight work-life imbalance, wage gap for female pediatricians September 13, 2019 Add Topic To Email Alerts Please provide your email address to receive an email when new articles are posted on this topic . Submit Receive an email when new articles are posted on this topic . CLICK HERE TO SUBSCRIBE Click here to manage your alerts . Amy J. Starmer Two studies published recently in Pediatrics highlighted female pediatricians’ work …

New research collaboratory designed to spur innovation and improve dementia care | 9/13/2019

To spur innovation to meet the challenges of complex care management for people with Alzheimer’s disease and related dementias (AD/ADRD) and their families, the National Institute on Aging (NIA), part of the National Institutes of Health, has funded a new effort designed to test care interventions in real-world settings. To spur innovation to meet the challenges of complex care management for people with Alzheimer’s disease and related dementias …

Circular RNA Found to Stimulate Cancer Progression | 9/13/2019

… Under certain conditions, RNA processing systems can get tricked into thinking they are supposed to join the ends,” said Mona Batish, a molecular biologist at the University of Delaware, who collaborated with scientists at Harvard Medical School and the University of California, Los Angeles (UCLA) on the study. “When this error occurs,” Batish went on, “it creates a backwards loop in the RNA’s genetic sequence and then keeps on going …

Old Patent Drawings | Google Patents | Adult Coloring Book | 9/13/2019

A Coloring Book of the Most Maniacal Patent Drawings You’ll Ever See Our 10 favorite contraptions include chicken glasses, saluting hats, and something called “sandwiched bread.” Sep 13, 2019 Popular Mechanics Do you like inventions ? Coloring to take the stress away? What about robot rides, mechanical frogs, and—wait for it—chicken glasses? If you responded “yes” to any of these questions, then this throwback patent coloring book, put together …

AMA

NIH announces six inaugural Genomic Innovator Awards | National Institutes of Health (NIH) | 8/27/2019

… the frequent use of mouse models around the globe, addressing these challenges may have lasting impact on biomedical research. Eric Gamazon, Ph.D., at Vanderbilt University Medical Center, Nashville, Tennessee, studies the genomic and environmental basis … which genomic variation influences disease risk. Jason Vassy, Ph.D., at Harvard Medical School, Boston, aims to develop and validate clinical polygenic risk scores for six common diseases: coronary artery disease, atrial fibrillation, type 2 diabetes …

3 Career Lessons From Iron Mike Tyson | Forbes | 8/26/2019

… Tyson’s preparation as a champion, I wanted to understand how he’s cultivated resilience over time. Tyson met his mentor, Cus D’Amato early on at age 13, he predicted that he would be the youngest heavyweight … would say. Dr. Srini Pillay, Assistant Professor of Psychiatry at Harvard Medical School, says that studies now show how self-talk can change brain blood flow. It’s important because you can learn how to talk …

ACO

PARTNERS HEALTHCARE TRANSITIONING INTO MEDICARE SHARED SAVINGS PROGRAM | Globe Newswire | 8/22/2019

… the Medicare Shared Savings Program (MSSP) through the Centers for Medicare and Medicaid Services (CMS). The MSSP Accountable Care Organization (ACO) allows Partners to extend care to roughly 10,000 additional patients, serving a total of … leading biomedical research organizations and a principal teaching affiliate of Harvard Medical School. Partners HealthCare is a non-profit organization. Richard Copp Partners HealthCare 6172781031 [email protected] Related Articles More articles issued by Partners HealthCare …

Hospitals treat patients without admitting them, to avoid penalties | Yahoo News | 8/22/2019

… Deaconess Medical Center and Harvard Medical School in Boston, who led the study. Since 2012, an initiative by the Centers for Medicare and Medicaid Services (CMS) to improve the quality and value of patient care, known as the Hospital Readmissions Reduction Program (HRRP), has imposed financial penalties on hospitals with higher-than-expected rates of readmission within 30 days of discharge for patients initially admitted for heart failure, heart attack …

ACA

Academia Uneasy With Lack Of Diversity On ‘Dude Walls’ Honor’ : Shots - Health News : NPR | 8/25/2019

What Our Monuments (Don’t) Teach Us About Remembering The Past He grew up reading Harry Potter books, and in that fictional world, portraits can talk to the characters. “If this was Harry Potter,” he muses, “if they could speak, what would they even say to me? Everywhere you study, there’s a big portrait somewhere of someone kind of staring you down.” Yale medical student Nientara Anderson recently teamed up with …

Nearly 200,000 trans people have been exposed to conversion therapy, study says | NBC News | 8/16/2019

… been condemned by nearly every major health association, including the American Medical Association, the American Psychological Association and the American Academy of Pediatrics. Using data from the National Center for Transgender Equality’s 2015 U.S. Transgender … prevalent,” Dr. Jack Turban, a resident physician in psychiatry at Harvard Medical School and the study’s lead author, told NBC News in an email. Related NBC OUT NBC OUT Thousands of teens spared conversion therapy …

National Institutes of Health

New research collaboratory designed to spur innovation and improve dementia care | 9/13/2019

… with Alzheimer’s disease and related dementias (AD/ADRD) and their families, the National Institute on Aging (NIA), part of the National Institutes of Health, has funded a new effort designed to test care interventions in … Providence, Rhode Island, will partner with Hebrew Senior Life, a Harvard Medical School Affiliate, Roslindale, Massachusetts, to manage the Imbedded Pragmatic AD/ADRD Clinical Trials (IMPACT) Collaboratory with funding from NIA that is expected to …

Network to Promote Real-World Dementia Trials | 9/11/2019

National Institutes of Health. A team from Brown University’s school of public health and Hebrew SeniorLife, a senior care center and research institute affiliated with Harvard Medical School, aim to establish ways for assisted-living and senior care facilities to readily test new techniques for caring for people with Alzheimer’s disease or related dementia. The researchers say innovations in care for people with Alzheimer’s disease is hampered by the lack …

Medicare

Medicare-for-all is not Medicare, and not really for all. So what does it actually mean? | 9/13/2019

Sen. Bernie Sanders has made “Medicare for All” a rallying cry of his campaign. By Akilah Johnson Propublica G AITHERSBURG, Md. — Ritchard Jenkins reached into the black computer bag he keeps near his workstation at … of Physicians for a National Health Program and instructor at Harvard Medical School, who supports calling it Medicare-for-all but acknowledges pitfalls with the framing. This “is an issue that affects, literally, every single

What Does ‘Medicare For All’ Actually Mean? | 9/8/2019

Medicare-for-all is what health care experts call single-payer: A system in which a government entity reimburses doctors and hospitals at a set rate. Many of the world’s most admired health care systems … of Physicians for a National Health Program and instructor at Harvard Medical School, who supports calling it Medicare-for-all but acknowledges pitfalls with the framing. This “is an issue that affects, literally, every single

NIH

Lawrence Lessig: What Leads to Academic Corruption? | 9/9/2019

Harvard Medical School are not paid by Harvard. Their salary comes from someone else. Lawrence Lessig: So they raise their salaries. So they raise their salary sometimes from the NHS, sometimes, I’m sorry, NIH in America. Sometimes from research grants from drug companies or pharmaceutical or device manufacturers. But the point is their money to do their work comes from outside the academy. And so there’s a question. What is …

Foundation for the NIH Names Finalists of the 2019 Trailblazer Prize for Clinician-Scientists | PR Newswire | 9/4/2019

BETHESDA, Md. The Foundation for the National Institutes of Health (FNIH) has selected the finalists of the 2 nd annual Trailblazer Prize for Clinician-Scientists (Trailblazer Prize): Ami S. Bhatt , M.D., Ph.D., Stanford University , James Kochenderfer , M.D., National Cancer Institute (NCI), Evan Macosko , M.D., Ph.D., Broad Institute and Giovanni Traverso, M.B., B.Chir, Ph.D., Massachusetts Institute of Technology ( MIT ) and Brigham and Women’s Hospital, Harvard Medical School . With work spanning the …

Mental Health

World Leading Mental Health Experts Join SilverCloud Health’s Expanded Clinical Advisory Board | PR Newswire | 9/12/2019

BOSTON , Sept. 12, SilverCloud Health , the world’s leading digital mental health platform, today announced the addition of five renowned mental health experts to the company’s clinical advisory board. Professors David H. Barlow , Ph.D., Todd Farchione … the Joslin Diabetes Center in Boston , a faculty member at Harvard Medical School and Chairman of the National Certification Board for Diabetes Educators. Professor Taylor is a research professor and director of the Center for

American Foundation for Suicide Prevention Invests $6.2M in Scientific Research to Prevent Tenth Leading Cause of Death | PR Newswire | 9/4/2019

… public education events. Many of the AFSP grantees then go on to receive further funding from the National Institute of Mental Health and other large funding agencies. The 26 grants awarded this year address six … Doyle, PhD, Assistant Professor of Psychiatry Location: Massachusetts General Hospital/ Harvard Medical School , Boston, MA The American Foundation for Suicide Prevention is dedicated to saving lives and bringing hope to those affected by suicide. AFSP …

Food and Drug Administration

Nature’s Nutraceutical | 9/9/2019

… evidence of health problems associated with the use of pure CBD. A good start for advocates. And according to a Harvard Medical School blog post by Peter Grinspoon, MD, the strongest scientific evidence for CBD … sold as a supplement, not a medication, and currently the Food and Drug Administration in the US doesn’t regulate the safety and purity of dietary supplements. This means you can’t be certain that the product …

bluebird bio to Present Data from Clinical Development Program of Lenti-DTM Gene Therapy for Cerebral Adrenoleukodystrophy (CALD) at the 13th European Pediatric Neurology Society (EPNS) Congress | Business Wire | 9/3/2019

… with Cerebral Adrenoleukodystrophy (CALD) Presenter: Dr. Florian Eichler, Center for Rare Neurological Diseases, Associate Professor of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, USA Date & Time (Parallel Session 2D: Neurometabolic Disorders I): Wednesday, September … designation for the treatment of adrenoleukodystrophy (ALD). The United States Food and Drug Administration granted Lenti-D Orphan Drug status for the treatment of ALD, and Rare Pediatric Disease designation and Breakthrough Therapy designation for …

Medical Research

NEWSMAKER: Dr. Rudolph Tanzi, rock star scientist | 9/13/2019

Medical Research building in Charlestown is decorated with accolades to Dr. Rudolph “Rudy” Tanzi. The wall is lined with awards for his scientific discoveries, his various academic degrees and a key to his native city of Cranston, Rhode Island. Next to the office door is a portrait of his 11-year-old daughter, Lila. In 1984, while Tanzi was a student at Harvard Medical School, trying to map the genetic …

Medicaid

PARTNERS HEALTHCARE TRANSITIONING INTO MEDICARE SHARED SAVINGS PROGRAM | Globe Newswire | 8/22/2019

… GLOBE NEWSWIRE) – Partners HealthCare is now participating in the Medicare Shared Savings Program (MSSP) through the Centers for Medicare and Medicaid Services (CMS). The MSSP Accountable Care Organization (ACO) allows Partners to extend care to … leading biomedical research organizations and a principal teaching affiliate of Harvard Medical School. Partners HealthCare is a non-profit organization. Richard Copp Partners HealthCare 6172781031 [email protected] Related Articles More articles issued by Partners HealthCare …

Hospitals treat patients without admitting them, to avoid penalties | Yahoo News | 8/22/2019

Harvard Medical School in Boston, who led the study. Since 2012, an initiative by the Centers for Medicare and Medicaid Services (CMS) to improve the quality and value of patient care, known as the Hospital Readmissions Reduction Program (HRRP), has imposed financial penalties on hospitals with higher-than-expected rates of readmission within 30 days of discharge for patients initially admitted for heart failure, heart attack or pneumonia. In fiscal …

Merck

Bristol-Myers Squibb Board Announces Election of Three New Directors | Business Wire | 9/12/2019

… as Chief Executive Officer and a member of the Board of Directors of Cubist Pharmaceuticals Inc. (which was acquired by Merck & Co., Inc. in January 2015) from June 2003 until December 2014. Prior to Cubist … graduate of Princeton, Dr. Haller received her M.D. degree from Harvard Medical School. She served as the first female Chief Resident at the Wilmer Eye Institute at Johns Hopkins and later joined the Johns Hopkins …

Genfit: GENFIT: Dr. Carol L. Addy Joins as Chief Medical Officer Paris Stock Exchange:GNFT | Globe Newswire | 9/9/2019

Merck & Co., and as Associate Director, Director and Senior Principal Scientist at Merck Research Laboratories. In addition to an M.D. degree, she holds a Masters of Medical Science from Harvard Medical School, Boston, MA, and has also been an endocrinology consultant for MIT Medical, Cambridge, MA. Dr. Carol L. Addy, MD, Chief Medical Officer of GENFIT, commented: “I’m thrilled to be joining GENFIT at this exciting time for the company …

Novartis

New England Choice Awards in Academics, Art, Business, Healthcare, Community Service, Philanthropy, Non-Profit and Youth Categories Announced | PR Newswire | 9/8/2019

… small molecules. Mr. Batra has also held senior positions at McKinsey and Company, a global strategy and consulting company, and Novartis, a swiss multinational pharmaceutical company. He serves as the chairman of the Massachusetts High … Clinical Oversight Committee at Joslin Diabetes Center Associate Clinical Professor, Harvard Medical School Dr. Ganda is medical director of the Lipid Clinic, and Chair of the Clinical Oversight Committee at Joslin Diabetes Center in Boston …

Novartis PARAGON-HF trial suggests Entresto® benefit in HFpEF patients but narrowly misses primary endpoint | Globe Newswire | 9/1/2019

September 01, 2019 08:30 ET Source: Novartis International AG Entresto (sacubitril/valsartan) reduced the composite of total (first and recurrent) heart failure hospitalizations and cardiovascular death although narrowly missed statistical significance (p = 0.059)[1] Totality … Director of Noninvasive Cardiology at Brigham and Women’s Hospital, Professor, Harvard Medical School, and PARAGON-HF Executive Committee Co-Chair. “PARAGON-HF provides a wealth of data that will advance our understanding of HFpEF and

Pfizer

Oncternal Expands Leadership Team with Appointment of Frank Hsu, M.D., as Chief Medical Officer, and Rajesh Krishnan, Ph.D., as Senior VP CMC and Manufacturing | Business & Finance | heraldchronicle.com | Business Wire | 8/28/2019

… the Yale Cancer Center. Dr. Hsu holds a B.S. degree in biology from Stanford University, and an M.D. degree from Harvard Medical School and the Health Science and Technology Program at the Massachusetts Institute of … of increasing responsibility at Merck & Co., Inc., Amgen Inc. and Pfizer from 2000 through 2012. Dr. Krishnan holds a B.S.E. degree in chemical engineering from Princeton University, an M.S. degree in chemical engineering from the …

Shared epitope defines distinct associations of cigarette smoking with levels of anticitrullinated protein antibody and rheumatoid factor | BMJ | 8/19/2019

… epitope defines distinct associations of cigarette smoking with levels of anticitrullinated protein antibody and rheumatoid factor 1 Joslin Diabetes Center , Harvard Medical School , Boston , Massachusetts , USA 2 Laboratory for Statistical and Translational Genetics, Center for … and Eisai). MT received scholarship donations from seven pharmaceutical companies (Pfizer Japan Inc., Astellas, Takeda Pharmaceutical, AbbVie GK Inc., Taisho-Toyama Pharmaceutical, Eisai and Asahi-Kasei). HI received scholarship donations from three pharmaceutical companies (Astellas …

Bristol-Myers Squibb

Bristol-Myers Squibb Board Announces Election of Three New Directors | Business Wire | 9/12/2019

NEW YORK- Bristol-Myers Squibb Company (NYSE:BMY) today announced that its Board of Directors has elected three new independent Directors: Michael Bonney, Dr. Julia A. Haller and Phyllis Yale will join the Board effective … graduate of Princeton, Dr. Haller received her M.D. degree from Harvard Medical School. She served as the first female Chief Resident at the Wilmer Eye Institute at Johns Hopkins and later joined the Johns Hopkins

Shared epitope defines distinct associations of cigarette smoking with levels of anticitrullinated protein antibody and rheumatoid factor | BMJ | 8/19/2019

… epitope defines distinct associations of cigarette smoking with levels of anticitrullinated protein antibody and rheumatoid factor 1 Joslin Diabetes Center , Harvard Medical School , Boston , Massachusetts , USA 2 Laboratory for Statistical and Translational Genetics, Center for … Lilly). MH received scholarship donations from three pharmaceutical companies (Astellas, Bristol-Myers Squibb and Eisai). MT received scholarship donations from seven pharmaceutical companies (Pfizer Japan Inc., Astellas, Takeda Pharmaceutical, AbbVie GK Inc., Taisho-Toyama Pharmaceutical …

WebMD

Could Fluoride Be Bad for Baby During Pregnancy? - WebMD | 8/19/2019

Expectant moms with higher levels of fluoride in their urine tended to have kids with lower average IQs, based on a study of 601 mother-child pairs from six cities in Canada. On average, a 1 milligram-per-liter increase in maternal urinary fluoride was associated with a 4.5-point lower IQ score in boys by the time they reached ages 3 to 4, researchers report. “Four and a half …

Bill Hambrecht Leads $15 Million Funding Round For Buoy Health | Forbes | 8/16/2019

… investors F-Prime Capital (Fidelity Investments) and Optum Ventures also contributed. On the surface, Buoy Health seems like an advanced WebMD. Click your symptoms and the Buoy chatbot asks related questions and then, using an … was completing his residency rotation in the emergency room of Harvard Medical School. “I was seeing all these patients who were Googling their symptoms before going to the ER,” he says, describing the plethora of …

Bristol-Myers

Bristol-Myers Squibb Board Announces Election of Three New Directors | Business Wire | 9/12/2019

NEW YORK- Bristol-Myers Squibb Company (NYSE:BMY) today announced that its Board of Directors has elected three new independent Directors: Michael Bonney, Dr. Julia A. Haller and Phyllis Yale will join the Board effective … graduate of Princeton, Dr. Haller received her M.D. degree from Harvard Medical School. She served as the first female Chief Resident at the Wilmer Eye Institute at Johns Hopkins and later joined the Johns Hopkins

Shared epitope defines distinct associations of cigarette smoking with levels of anticitrullinated protein antibody and rheumatoid factor | BMJ | 8/19/2019

… epitope defines distinct associations of cigarette smoking with levels of anticitrullinated protein antibody and rheumatoid factor 1 Joslin Diabetes Center , Harvard Medical School , Boston , Massachusetts , USA 2 Laboratory for Statistical and Translational Genetics, Center for … Lilly). MH received scholarship donations from three pharmaceutical companies (Astellas, Bristol-Myers Squibb and Eisai). MT received scholarship donations from seven pharmaceutical companies (Pfizer Japan Inc., Astellas, Takeda Pharmaceutical, AbbVie GK Inc., Taisho-Toyama Pharmaceutical …

IM Health

Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society* Clinical Practice… | National Institutes of Health | 8/1/2019

Hebrew Rehabilitation Hospital, Boston, Massachusetts. 2 University of Chicago Medicine, Chicago, Illinois. 3 University of California Davis, Sacramento, California. 4 Harvard Pilgrim Health Care Institute, Harvard Medical School, Boston, Massachusetts. 5 Harvard Medical School, Boston, Massachusetts. 6 Johns Hopkins University School of Medicine, Baltimore, Maryland. 7 Evidence-Based Practice Center, Mayo Clinic, Rochester, Minnesota. 8 Centre Hospitalier Universitaire Dijon Bourgogne, Dijon, France. Abstract OBJECTIVE: To develop clinical practice guidelines for …

Blue Cross’s approach to paying doctors based on quality of care shows results, Harvard study finds - The Boston Globe | 7/18/2019

… a potential strategy to combat one of the most vexing problems in today’s economy. In a new study, researchers at Harvard Medical School found that a payment plan from Blue Cross Blue Shield of Massachusetts … watched since it began in 2009. Other insurers, including Harvard Pilgrim Health Care and Tufts Health Plan, have since launched similar programs. The federal government has also pushed new payment plans in Medicare through accountable …

Health Catalyst

Harvard Researchers To Explore Cannabis As Medicine For Less-Affluent Nations | Yahoo News | 7/8/2019

Harvard Medical School, was launched on May 26 during the 2019 Global Health Catalyst summit at Harvard Medical School, an annual conference focused primarily on reducing disparities to access to healthcare. Phytomedicine is a plant-based medicinal practice that utilizes plant materials for preventive and therapeutic purposes Cannabis is one of the primary plants the IPI will begin studying. The IPI aims to apply the wealth of science and technology …

Cannabis Companies That are Thriving Thanks to 2018 U.S. Farm Bill | PR Newswire | 6/11/2019

Harvard Medical School. The International Phytomedicines Institute (IPI), launched during this year’s Harvard GHC Summit, is a transformative initiative by the Global Health Catalyst designed to elevate phytomedicines in global health, accelerate clinical translation and commercialization of evidence-based plant medicines/healthcare products and provide a world class core facility for research, and consultation on medicinal plants. The IPI aims to leverage the best science, technology, and education from Harvard …

Celgene

Bristol-Myers Squibb Board Announces Election of Three New Directors | Business Wire | 9/12/2019

… Bonney, Dr. Julia A. Haller and Phyllis Yale will join the Board effective at the closing of the transaction with Celgene Corporation (NASDAQ: CELG). In connection with these elections, the size of the Board will … graduate of Princeton, Dr. Haller received her M.D. degree from Harvard Medical School. She served as the first female Chief Resident at the Wilmer Eye Institute at Johns Hopkins and later joined the Johns Hopkins …

2nd Annual Next Gen Immuno-Oncology Congress (Philadelphia, PA, United States - September 19-20, 2019) - The Next Step Towards Changing Treatment Paradigms in Immuno-Oncology | Globe Newswire | 8/29/2019

… Therapeutics B7-H3, an attractive target of antibody-based immunotherapy 11:55 - 12:25 Soldano Ferrone, Professor of Surgery, Massachusetts General Hospital, Harvard Medical School Role of Immune Activation Profiling in clinical trials 12:25 - 12:55 Lunch and … 10:05 - 11:25 Stefan Glueck, Senior Vice President, Global Medical Affairs, Celgene Comparing immunological marker signatures across various cancer types 11:25 - 11:55 Natalie Russi, Scientific Project Manager, Nebion Systematic Approaches to Identifying and Overcoming Resistance to …

Grand Rounds

CC Grand Rounds: Grand Rounds: Contemporary Issues in Graduate Medical Education: Optimizing Evaluation, Feedback and Coaching in Fellowship Training | National Institutes of Health | 6/26/2019

CC Grand Rounds: Grand Rounds: Contemporary Optimizing Evaluation, Feedback and Coaching in Fellowship TrainingFor Debra Weinstein, MD, Associate Professor of Medicine, Harvard Medical School and Vice President for Graduate Medical Education, Partners HealthCare Runtime …

CC Grand Rounds: Contemporary Issues in Graduate Medical Education: Respect and Trust: Key to a Culture of Safety | National Institutes of Health | 6/26/2019

CC Grand Rounds: Contemporary Respect and Trust: Key to a Culture of SafetyFor Jo Shapiro, MD, Director, Center for Professionalism and Peer Support and Associate Professor of Otolaryngology, Harvard Medical School Runtime …

MPM Capital

Massachusetts General Hospital and ElevateBio Announce a 10-Year Alliance Agreement to Utilize ElevateBio BaseCamp to Manufacture Innovative Cell and Gene Therapies | Business Wire | 7/25/2019

… ahead.” About Massachusetts General Hospital Founded in 1811, Massachusetts General Hospital ( www.massgeneral.org ) is the original and largest teaching hospital of Harvard Medical School. The 1,000-bed medical center each year admits approximately 50,000 inpatients, handles … investors are the UBS Oncology Impact Fund (OIF) managed by MPM Capital, as well as F2 Ventures. Investors also include EcoR1 Capital, Redmile Group, and Samsara BioCapital. ElevateBio has established ElevateBio BaseCamp, a single R …

Versant Ventures

Inari Medical Appoints Thomas M. Tu, M.D. as Chief Medical Officer | PR Newswire | 7/3/2019

… solutions, and train many more physician users, Tom’s expertise and perspective will be invaluable.” Dr. Tu is a graduate of Harvard Medical School. He completed his medical and cardiology training at Massachusetts General Hospital and … device incubator. The company is backed by Gilde Healthcare ( www.gildehealthcare.com ), Versant Ventures ( www.versantventures.com ) and U.S. Venture Partners ( www.usvp.com ). For more information, please visit www.inarimedical.com . Contact Tara Dunn , Vice President Clinical Affairs [email protected] SOURCE Inari …

Inari Medical Appoints Thomas M. Tu, M.D. as Chief Medical Officer | Markets Insider | Business Insider | 7/2/2019

… solutions, and train many more physician users, Tom’s expertise and perspective will be invaluable.” Dr. Tu is a graduate of Harvard Medical School. He completed his medical and cardiology training at Massachusetts General Hospital and … device incubator. The company is backed by Gilde Healthcare (www.gildehealthcare.com), Versant Ventures (www.versantventures.com) and U.S. Venture Partners (www.usvp.com). For more information, please visit www.inarimedical.com. Contact Tara Dunn , Vice President Clinical Affairs [email protected] View original …

New Enterprise Associates

Regulus Announces New Additions to Board of Directors | PR Newswire | 6/11/2019

… Company,” said Stelios Papadopoulos , Ph.D., Chairman of the Board of Directors of Regulus. Mr. Nunn is a venture advisor at New Enterprise Associates (NEA) and Dr. Simeonidis is a partner with Sarissa Capital. Both NEA … his corporate career, having served as a faculty member at Harvard Medical School. Dr. Simeonidis received his BS in Biology from Loyola University Chicago , and his MA, MPhil and PhD degrees in Cellular, Molecular and …

Regulus Announces New Additions to Board of Directors | Business & Finance | manchestertimes.com | PR Newswire | 6/11/2019

… Company,” said Stelios Papadopoulos, Ph.D., Chairman of the Board of Directors of Regulus. Mr. Nunn is a venture advisor at New Enterprise Associates (NEA) and Dr. Simeonidis is a partner with Sarissa Capital. Both NEA … his corporate career, having served as a faculty member at Harvard Medical School. Dr. Simeonidis received his BS in Biology from Loyola University Chicago, and his MA, MPhil and PhD degrees in Cellular, Molecular and …

Atlas Venture

Harvard Business School Announces $10 Million Gift Renewal from the Blavatnik Family Foundation and Introduces 2019-2020 Blavatnik Fellows in Life Science Entrepreneurship | Markets Insider | Business Insider | 6/6/2019

… for his generous and continuous support of the Fellowship,” said Peter Barrett , PhD, senior fellow at HBS and partner at Atlas Venture, who directs the Blavatnik Fellowship with support from a Key Advisory Board of … medical student, Davlin co-founded the Makerspace prototyping lab at Harvard Medical School to support student entrepreneurs. He has co-developed several mobile applications including an app to measure tissue perfusion using a cell phone …

Khosla Ventures

Khosla leads $12M series B for digital health player Hello Heart | FierceBiotech | 8/2/2019

… rather than raise it. Digital health tool developer Hello Heart reeled in a $12 million series B round led by Khosla Ventures to help bankroll the expansion of its sales and engineering teams. The California … users, researchers from the University of California, Los Angeles and Harvard Medical School found that the program helped 57% reduce their blood pressure after four weeks and 69% after 22 weeks. The findings, which appear …

Flagship Pioneering

The Galien Foundation Debuts 2019 Prix Galien USA Nominees in “Best Biotechnology Product,” “Best Pharmaceutical Product,” and “Best Medical Technology” Categories | PR Newswire | 7/15/2019

… of Texas Southwestern Medical Center , Dallas, TX Laurie GLIMCHER , M.D., CEO and President, Dana Farber Cancer Institute, Professor of Medicine, Harvard Medical School , Cambridge, MA Joseph GOLDSTEIN , M.D., Nobel Laureate, Professor of Molecular Genetics and … Cancer Center, NYC, NY Michael ROSENBLATT , M.D., Chief Medical Officer, Flagship Pioneering Inc, Cambridge, MA Bengt SAMUELSSON , M.D., Ph.D., Nobel Laureate, Former President, Karolinska Institute ; Former Chairman, Nobel Foundation Marc TESSIER-LAVIGNE , Ph.D., President, Stanford …

Sana Biotechnology plans move to new Cambridge offices after rapid expansion | The Business Journals | 5/17/2019

… plans to move to new, larger offices in the fall. Sana Biotechnology Inc., founded in 2018 by Cambridge VC firm Flagship Pioneering and former Juno executives Hans Bishop and Steve Harr , emerged from stealth mode … billion or greater. Sana’s Massachusetts offices are being led by Harvard Medical School professor and former CRISPR Therapeutics Chief Scientific Officer Chad Cowan. Flagship Pioneering Founder Noubar Afeyan is also serving on Sana’s board of …

Astellas Venture Management

Looking beyond cancer, Twentyeight-Seven Therapeutics bumps up series A to $82M+ | FierceBiotech | 5/10/2019

… as apply its work in disease areas other than cancer. The company was founded in 2016 around technology from four Harvard Medical School professors across multiple disciplines: biological chemistry, molecular pharmacology and RNA medicine. Richard … Fund, Johnson & Johnson Innovation, Vertex Ventures HC, Longwood Fund and Astellas Venture Management. Since then, the company has moved into new digs in Watertown, Massachusetts. Of the new funding, $15 million comes from Sofinnova Partners …

Partners Innovation Fund

Merck to buy VC-backed Tilos Therapeutics | PE Hub | 6/11/2019

… Therapeutics , a biopharmaceutical company, for a consideration of up to $773 million. Tilos is backed by Boehringer Ingelheim Venture Fund, Partners Innovation Fund and ShangPharma Innovation Fund. PRESS RELEASE KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE … of Dr. Howard Weiner at Brigham and Women’s Hospital and Harvard Medical School. Additional investment was provided by ShangPharma Innovation Fund. About TGFβ and LAP TGFβ is a potent cytokine believed to play an important …

Akouos to Build Premier Gene Therapy Company Focused on Hearing and Balance Disorders with Backing from Leading Life Science Investors and Strategic Licenses from Massachusetts Eye and Ear and Lonza | PR Newswire | 11/30/2017

… Eye and Ear and Lonza - Akouos raises $7.5 million in equity financing from 5AM Ventures, New Enterprise Associates (NEA), and Partners Innovation Fund.- Massachusetts Eye and Ear and Lonza grant Akouos exclusive licenses to proprietary … of Dr. Luk H. Vandenberghe , Assistant Professor of Ophthalmology at Harvard Medical School , and Director of the Grousbeck Gene Therapy Center at Massachusetts Eye and Ear. Under the terms of the agreements, Akouos obtains an …

Morgan Stanley

Regulus Announces New Additions to Board of Directors | PR Newswire | 6/11/2019

Morgan Stanley. In addition to his investment management and financial expertise, Dr. Simeonidis combines both biopharmaceutical industry and biomedical research expertise, having worked at Novartis in Business Development and Strategic Planning, and prior to his corporate career, having served as a faculty member at Harvard Medical School. Dr. Simeonidis received his BS in Biology from Loyola University Chicago , and his MA, MPhil and PhD degrees in Cellular, Molecular and Biophysical …

Regulus Announces New Additions to Board of Directors | Business & Finance | manchestertimes.com | PR Newswire | 6/11/2019

Morgan Stanley. In addition to his investment management and financial expertise, Dr. Simeonidis combines both biopharmaceutical industry and biomedical research expertise, having worked at Novartis in Business Development and Strategic Planning, and prior to his corporate career, having served as a faculty member at Harvard Medical School. Dr. Simeonidis received his BS in Biology from Loyola University Chicago, and his MA, MPhil and PhD degrees in Cellular, Molecular and Biophysical …

HC2 Holdings

Blossom Innovations Advances Its Latest Medical Technology Platform for Dermatology | Business Wire | 6/13/2019

… will be commercialized by R2 Dermatology , a Blossom Innovations company. Founded in 2014 by Pansend Life Sciences, a subsidiary of HC2 Holdings and Blossom Innovations, R2 Dermatology recently entered into an agreement granting exclusive distribution … Wellman Center at Massachusetts General Hospital, a teaching affiliate of Harvard Medical School – Department of Dermatology; Dieter Manstein, M.D., Ph.D., Department of Dermatology at Massachusetts General Hospital; and Henry H.L. Chan, M.D., Ph.D., Department of …

R2 Dermatology Announces Signing of Exclusive Asia-Pacific Distribution Agreement with China’s Huadong Medicine Company Limited | Globe Newswire | 6/13/2019

June 13, 2019 08:30 ET Source: HC2 Holdings, Inc.; R2 Dermatology SAN RAMON, Calif., June 13, 2019 (GLOBE NEWSWIRE) – R2 Dermatology (“R2”) announced today that it has entered into an exclusive distribution agreement with China’s … by Blossom Innovations and Massachusetts General Hospital, teaching affiliate of Harvard Medical School. Learn more about R2 Dermatology at www.r2derm.com . Contact

Massachusetts General Hospital

New Supercooling Method Triples Organs Viability for Transplant | 9/14/2019

Massachusetts General Hospital (Mass General) and Harvard Medical School (HMS). Supercooling Way to Extend Donor Organs Shelf Life We need better organ storage protocols than the existing cooling and perfusion processes that can’t keep organs viable long enough until they’re transplanted into another body. Kept on ice , at 4 degrees Celsius, donor organs usually have an average of nine hours before cells start falling for irreparable ischemic damage . Compared to …

Presymptomatic Serum Neurofilament Light Chain Levels Before Multiple Sclerosis | 9/13/2019

Harvard Medical School, Boston, Massachusetts 5 Biostatistics Center, Massachusetts General Hospital, Boston, Massachusetts 6 Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland 7 Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts 8 Channing Division of Network Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts 13, 2019. doi:10.1001/jamaneurol.2019.3238 How long is the prodromal …

HCA

J. Mario Molina Named Founding Dean of the KGI School of Medicine | Business Wire | 8/27/2019

… founding dean of the KGI School of Medicine. Molina served for 20 years as the Chief Executive Officer of Molina Healthcare, a Fortune 500 company founded by his father in 1980 to provide healthcare to … Hopkins Medicine and served on the Visiting Committee for the Harvard Medical School. He is also a member of the Founder’s Council of the United States of Care. Medical education programs leading to the MD …

Beth Israel Deaconess Medical Center

Hospitals treat patients without admitting them, to avoid penalties | Yahoo News | 8/22/2019

Beth Israel Deaconess Medical Center and Harvard Medical School in Boston, who led the study. Since 2012, an initiative by the Centers for Medicare and Medicaid Services (CMS) to improve the quality and value of patient care, known as the Hospital Readmissions Reduction Program (HRRP), has imposed financial penalties on hospitals with higher-than-expected rates of readmission within 30 days of discharge for patients initially admitted for heart failure …

Ritter Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2019 and Provides a Corporate Update | Markets Insider | Business Insider | 8/14/2019

Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School. ● Confirmed alignment with FDA on key elements of the Phase 3 “Liberatus” trial’s Statistical Analysis Plan, including the primary endpoint, secondary endpoints and other critical components “Our focus in Q2 2019 was to ensure completion of all patient visits in our Phase 3 Liberatus clinical trial and to expand on our understanding of the lactose intolerance market …

Massachusetts General Hospital, Boston MA

Presymptomatic Serum Neurofilament Light Chain Levels Before Multiple Sclerosis | 9/13/2019

September 13, 2019 Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis Author Affiliations Article Information 1 Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, Massachusetts 2 Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland 3 Partners Multiple Sclerosis Center, Brigham and Women’s Hospital, Boston, Massachusetts 4 Department of Neurology, Harvard Medical School

Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer | 9/13/2019

Translational Cancer Mechanisms and Therapy Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer Sophia C. Kamran , Jochen K. Lennerz , Claire A. Margolis , David Liu , Brendan Reardon , Stephanie A. Wankowicz , Emily E. Van Seventer , Adam Tracy , Jennifer Y. Wo , Scott L. Carter , Henning Willers , Ryan B. Corcoran , Theodore S. Hong and Eliezer M. Van Allen Sophia C. Kamran Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School

Brigham and Women's Hospital

Quality of care in large Chinese hospitals: an observational study | BMJ | 5/20/2019

Li Yao 8 , Winnie C Yip 9 1 Department of Health Policy and Management , Peking University Health Science Center School of Public Health , Beijing , China 2 Center for Health Policy and Technology Evaluation , Peking University Health Science Centre , Beijing , Beijing , China 3 Department of Medicine , Harvard Medical School , Boston , Massachusetts , USA 4 Department of Medicine , Brigham and Women’s Hospital , Boston , Massachusetts , USA 5 Department of Health Policy , London School of …

Alzheimer’s Clinical Trials Consortium Selects Elenbecestat and BAN2401 for Upcoming Clinical Studies on Prevention of Alzheimer’s Disease - NASDAQ.com | 5/14/2019

Brigham and Women’s Hospital and Massachusetts General Hospital, Harvard Medical School. “The A3 and A45 Studies should provide critically important answers about the optimal time to intervene with anti-amyloid therapy, with the hope that starting treatment much earlier in the disease process may be advantageous in preventing future cognitive decline,” said Dr. Sperling, Director, Center for Alzheimer Research and Treatment at Brigham and Women’s Hospital and co-Principal Investigator …

Mayo Clinic

Patient Priorities Should be Paramount when Measuring Quality in Cancer Care According to Panelists at NCCN Policy Summit | PR Newswire | 9/12/2019

… department visits, which may not necessarily reflect poor quality,” said Nancy Keating , MD, MPH, Professor of Health Care Policy & Medicine, Harvard Medical School . “Patient experience is a key aspect of quality, but collecting that data … H. Lurie Comprehensive Cancer Center of Northwestern University , Chicago, IL ; Mayo Clinic Cancer Center, Phoenix / Scottsdale, AZ , Jacksonville, FL , and Rochester, MN ; Memorial Sloan Kettering Cancer Center, New York, NY ; Moffitt Cancer Center, Tampa, FL …

New research, recent controversies question vitamin D benefits in CVD | 9/6/2019

… cure it,” Bart L. Clarke, MD, professor of medicine in the division of endocrinology, metabolism, diabetes and nutrition at the Mayo Clinic College of Medicine in Rochester, Minnesota, and president of the American Society for … Manson, MD, DrPH, FAHA, from Brigham and Women’s Hospital and Harvard Medical School, said there is no blanket recommendation on vitamin D supplementation for CVD prevention. Source: Cardiology Today. What constitutes the “optimal” level of …

Partners HealthCare

PARTNERS HEALTHCARE TRANSITIONING INTO MEDICARE SHARED SAVINGS PROGRAM | Globe Newswire | 8/22/2019

Extending Care to More Patients; Increasing Commitment to Value-Based Care August 22, 2019 13:53 ET Source: Partners HealthCare Boston, Aug. 22, 2019 (GLOBE NEWSWIRE) – Partners HealthCare is now participating in the Medicare Shared Savings … leading biomedical research organizations and a principal teaching affiliate of Harvard Medical School. Partners HealthCare is a non-profit organization. Richard Copp Partners HealthCare 6172781031 [email protected] Related Articles More articles issued by Partners HealthCare

Kaiser Appoints First Chief Digital Officer, Teladoc’s New COO, Castlight Health CEO, Other Health IT Appointments | HIT Consultant | 8/5/2019

Partners HealthCare, and Professor of Dermatology at Harvard Medical School. Dr. Kvedar previously served as President of ATA from 2004-2005, and was a member of the Board of Directors from 2002-2006. Maeve O’Meara, CEO, Castlight Health Castlight Health appoints Maeve O’Meara as the company’s CEO and a seat on its Board of Directors. Siobhan Nolan Mangini will serve as the company’s President and retain her position of Chief Financial Officer …

Kaiser Permanente

Alcohol and drug use, partner PrEP use and STI prevalence among people with HIV | BMJ | 8/23/2019

Derek D Satre 1 , 2 1 Weill Institute for Neurosciences, Department of Psychiatry , University of California , San Francisco , California , USA 2 Kaiser Permanente Division of Research , Oakland , California , USA 3 Department of Population Medicine , Harvard Medical School , Boston , Massachusetts , USA 4 Department of Adult and Family Medicine , Kaiser Permanente San Francisco Medical Center , San Francisco , California , USA 5 Department of Research and Evaluation , Kaiser Permanente Southern California , Pasadena , California , USA …

Shopping Abroad For Cheap Medication? Here’s What to Know | Money | Becker’s Hospital Review | 8/19/2019

… the country has strong pharmacy regulations, says Dr. Aaron S. Kesselheim, a professor of medicine at Brigham & Women’s Hospital and Harvard Medical School. (Read below for websites that can help with that.) Countries with well … the California Health Care Foundation . KHN is not affiliated with Kaiser Permanente. You May Like …

Boston Children's Hospital

Hasbro and Boston Children’s Hospital Find Scientific Evidence Linking Play to Positive Child Development | Business Wire | 7/31/2019

New Research from Hasbro and Boston Children’s Hospital Finds Scientific Evidence of the Benefits of Play AP Hasbro and Boston Children’s Hospital Find Scientific Evidence Linking Play to Positive Child Development 5 hrs ago New … said Rich, who is also Associate Professor of Pediatrics at Harvard Medical School and Associate Professor of Social and Behavioral Sciences at the Harvard T. H. Chan School of Public Health. Initial findings from the

Comparison of seasonal serum 25-hydroxyvitamin D concentrations among pregnant women in Mongolia and Boston. | National Institutes of Health | 7/20/2019

… 4 Mongolian Health Initiative Non-Governmental Organization, Bayanzurkh District, Ulaanbaatar, Mongolia. Electronic address: [email protected] 5 Department of Laboratory Medicine, Boston Children’s Hospital, 300 Longwood Avenue, Boston, MA, 02115, USA. Electronic address: [email protected] 6 … Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA, 02115, USA. Electronic address: [email protected] Abstract Adequate vitamin D status during pregnancy is important for developing …

Cambridge Health Alliance

Could a new drug treat veterans with severe depression? President Trump thinks so | Yahoo News | 8/27/2019

Cambridge Health Alliance and an assistant professor of psychiatry at Harvard Medical School who was not involved in the studies. “I’m open to giving esketamine consideration, but given the data we have and its high cost, there are other drugs and therapies we can maximize first,” he added. Boyd cautioned about trials supported by the pharmaceutical industry, like those used for Spravato, though it is not uncommon for pharmaceutical companies …

JAGGAER ONE Source to Pay Platform selected by Cambridge Health Alliance for Comprehensive Digital Transformation | Globe Newswire | 7/23/2019

… 2019 06:00 ET Source: JAGGAER RESEARCH TRIANGLE PARK, N.C., JAGGAER , the world’s largest independent spend management company, today announces that Cambridge Health Alliance (CHA) has selected the full suite of solutions in the JAGGAER ONE … metro-north region. It is also a teaching hospital of Harvard Medical School, Harvard School of Public Health, Harvard School of Dental Medicine and Tufts University School of Medicine. The system processes nearly $350M in …

Harvard Pilgrim Health Care

Blue Cross’s approach to paying doctors based on quality of care shows results, Harvard study finds - The Boston Globe | 7/18/2019

… a potential strategy to combat one of the most vexing problems in today’s economy. In a new study, researchers at Harvard Medical School found that a payment plan from Blue Cross Blue Shield of Massachusetts … closely watched since it began in 2009. Other insurers, including Harvard Pilgrim Health Care and Tufts Health Plan, have since launched similar programs. The federal government has also pushed new payment plans in Medicare through …

Science News » Novel Method Identifies Patients at Risk for HIV Who May Benefit From Prevention Strategies | National Institutes of Health | 7/8/2019

… empower them to prescribe PrEP more frequently,” said study author Douglas Krakower, M.D., of Beth Israel Deaconess Medical Center and Harvard Medical School. In two large-scale studies, which used EHRs from large health systems … led by Julia Marcus, Ph.D., of Harvard Medical School and Harvard Pilgrim Health Care Institute, with Krakower and colleagues, scaled-up this prediction approach by using the EHRs of more than 3.7 million patients receiving …

Health Net

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus | BMJ | 8/12/2019

… Center and Faculty of Medicine Carl Gustav Carus, TU Dresden , Dresden , Germany 2 Department of Medicine , Brigham and Women’s Hospital, Harvard Medical School , Boston , Massachusetts , USA 3 University of California at San Francisco and VA … of Barcelona , Barcelona , Spain 14 Medicine , Toronto Western Hospital, University Health Network, Mount Sinai Hospital, University of Toronto, Toronto Scleroderma Research Program , Toronto , Ontario , Canada 15 Center for Autoimmune, Musculoskeletal and Hematopoietic Diseases , The Feinstein …

Blue Cross Blue Shield Of Massachusetts

Mark Friedberg Joins Blue Cross Blue Shield Of Massachusetts Leadership Team | PR Newswire | 8/7/2019

BOSTON , Aug. 7, 2019 /PRNewswire/ – Blue Cross Blue Shield of Massachusetts (“Blue Cross”) announced today that Mark Friedberg , M.D., has joined its leadership team as senior vice president of performance measurement and improvement. Friedberg is … of medicine, part-time, at Brigham and Women’s Hospital and Harvard Medical School . Mark Friedberg named Senior Vice President of Performance Measurement and Improvement at Blue Cross Blue Shield of Massachusetts “Mark brings a strong

Blue Cross Blue Shield of Massachusetts slows spending growth with global budget: study | FierceHealthcare | 7/18/2019

A global budget model launched by Blue Cross Blue Shield of Massachusetts slowed healthcare spending growth by 12% over eight years, according to a new study. Blue Cross created the Alternative Quality Contract (AQC) in 2009, and researchers at Harvard Medical School studied claims data through 2016 to weigh the effectiveness of the model. Average annual claims for doctors in AQC were, on average, $461 less than physicians who were …

Humana

Patient Priorities Should be Paramount when Measuring Quality in Cancer Care According to Panelists at NCCN Policy Summit | PR Newswire | 9/12/2019

… department visits, which may not necessarily reflect poor quality,” said Nancy Keating , MD, MPH, Professor of Health Care Policy & Medicine, Harvard Medical School . “Patient experience is a key aspect of quality, but collecting that data … Loy , MD, MBA, Physician Lead – Oncology, Laboratory, and Personalized Medicine, Humana ; Jim Martineau , MBA, Director, Product Management & Operations, Flatiron ; Alexandra Chong , PhD, OCM Team Lead, Center for Medicare & Medicaid Innovation (CMMI) . NCCN Senior Policy and …

Bill Hambrecht Leads $15 Million Funding Round For Buoy Health | Forbes | 8/16/2019

… Thursday, Buoy Health announced a $15 million Series B funding round led by Hambrecht Ducera Growth Ventures. Health insurance company Humana joined the round as a strategic investor, and existing investors F-Prime Capital (Fidelity … was completing his residency rotation in the emergency room of Harvard Medical School. “I was seeing all these patients who were Googling their symptoms before going to the ER,” he says, describing the plethora of …

Aetna

Could Artificial Intelligence Do More Harm Than Good in Healthcare? - Xtelligent Healthcare Media | HealthIT Analytics | 6/25/2019

… have all clouded the otherwise clear vision of AI in healthcare, and could limit its role in the industry. At Harvard Medical School’s Precision Medicine Annual Conference in Boston last week, panelists discussed how to … Key industry players have launched initiatives to overcome security challenges. Aetna, Ascension, Humana and Optum have recently joined forces for the Synaptic Health Alliance , a collaborative pilot program that uses blockchain to create a secure …

AHIP19: Insurers acknowledge heightened cost pressures | Healthcare Dive | 6/24/2019

… up. Many of the nation’s largest insurers are now hitched to the biggest pharmacy benefit managers with CVS’ acquisition of Aetna and Cigna’s buy of Express Scripts. There is a growing feeling that insurance companies … news flash, they hate it,” Michael Chernew, an economist at Harvard Medical School, said during the conference. But the reason Medicare for All stays on the front burner, he said, is overall frustration with the …

Cigna

AHIP19: Insurers acknowledge heightened cost pressures | Healthcare Dive | 6/24/2019

… and consumers struggling to afford it. “Affordability is once again at the pinnacle of the conversation,” David Cordani, CEO of Cigna and chairman of AHIP, said in a speech opening the conference. Cordani likened the … news flash, they hate it,” Michael Chernew, an economist at Harvard Medical School, said during the conference. But the reason Medicare for All stays on the front burner, he said, is overall frustration with the …

CVS’s $68 Billion Bid to Bring One-Stop Shopping to Health Care - Bloomberg | 12/7/2017

Cigna Corp. “There’s a large majority of people who are truly driven by ease and convenience when it comes to their care.” Ateev Mehrotra, a professor at Harvard Medical School, says his research has found that retail clinics, by making care more convenient and accessible, actually raise health-care costs because people go to them more often. That’s bad news if you’re also an insurer. “The majority of visits we …

Healthspan

Joe Kvedar, MD Elected Next President of American Telemedicine Association | HIT Consultant | 7/25/2019

… President. Dr. Kvedar Background Dr. Kvedar is Vice President of Connected Health at Partners HealthCare , and Professor of Dermatology at Harvard Medical School. Dr. Kvedar previously served as President of ATA from 2004-2005, and was … subject: The New Mobile Age: How Technology Will Extend the Healthspan and Optimize the Lifespan (2017) and The Internet of Healthy Things (2015), and more than 1,000 publications. Beating The Drum on Telehealth Adoption “ATA …

Global Foundation for Human Aging Research Contributes $75,000 to Support the Dana-Farber Cancer Institute in its Cellular Aging Research | PR Newswire | 12/29/2017

Harvard Medical School . Dana Farber Cancer Institute Dr. Vincent Giampapa , the founder of the Global Foundation for Human Aging Research, believes specific nutraceuticals and drugs, as well as DNA segments, can be used to alter the gene activity of both somatic cells and stem cells to make them function more optimally during the aging process. He believes this is critical to extend healthspan and delay the onset of diseases of …

Blue Cross Blue Shield of Arizona

Dr. Woodrow Myers, Jr. Named New Chief Medical Officer and Health Strategist for Blue Cross Blue Shield of Arizona | PR Newswire | 1/3/2018

Dr. Woodrow Myers, Jr. Named New Chief Medical Officer and Health Strategist for Blue Cross Blue Shield of Arizona News provided by 14:00 ET Share this article PHOENIX , Jan. 3, 2018 /PRNewswire-USNewswire/ – Blue Cross … well as the state of Indiana . As an alumnus of Harvard Medical School and Stanford University , he has served as a member of their respective boards. “As the state’s largest locally-owned healthcare insurer, BCBSAZ

Molina Healthcare

J. Mario Molina Named Founding Dean of the KGI School of Medicine | Business Wire | 8/27/2019

… the founding dean of the KGI School of Medicine. Molina served for 20 years as the Chief Executive Officer of Molina Healthcare, a Fortune 500 company founded by his father in 1980 to provide healthcare … Hopkins Medicine and served on the Visiting Committee for the Harvard Medical School. He is also a member of the Founder’s Council of the United States of Care. Medical education programs leading to the MD …

George Church

‘Extraordinary’ Breakthroughs In Anti-Aging Research ‘Will Happen Faster Than People Think’ | Forbes | 8/26/2019

Harvard Medical School professor George Church, Market Watch reports. The company is testing 60 different age-reversing gene therapies. “The company, which carried out initial tests on beagles, claims it can reverse aging in animals by adding new DNA instructions to their bodies,” Market Watch reported. “It has announced plans to launch a trial later this year to combat mitral valve disease, a condition which is common in the Cavalier …

Companies race to find the key to eternal life - MarketWatch | 8/19/2019

Harvard Medical School professor George Church, is testing 60 different age-reversing gene therapies. The company, which carried out initial tests on beagles, claims it can reverse aging in animals by adding new DNA instructions to their bodies. It has announced plans to launch a trial later this year to combat mitral valve disease, a condition which is common in the Cavalier King Charles Spaniel breed and directly caused by …

Fred Hutchinson

Kronos Bio Expands Scientific Advisory Board with Addition of Roger D. Kornberg, Ph.D. | Business & Finance | manchestertimes.com | Business Wire | 8/7/2019

… has been a member of the faculty of Stanford University since 1972. Prior to that, he was a professor at Harvard Medical School. He was elected to the National Academy of Sciences in 1993 and … Allogene Therapeutics, Inc. Robert Eisenman, Ph.D. – Member, Basic Sciences Division, Fred Hutchinson Cancer Research Center; Affiliate Professor of Biochemistry, University of Washington School of Medicine Angela Koehler, Ph.D. – Associate Professor, Department of Biological Engineering, Massachusetts …

Perspective: Dietaryiomarkers of Intake and Exposure-Exploration with Omics Approaches. | National Institutes of Health | 8/6/2019

… Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA. 2 Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. 3 School of Public Health, University of … 16 Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. 17 Departments of Nutrition; Epidemiology and Statistics, Harvard TH Chan School of Public Health, Boston, MA, USA. 18 Channing …

Paul G. Richardson

Oncopeptides Announces Acceptance of Data for Presentation at International Myeloma Workshop, September 12-15 | PR Newswire | 8/17/2019

… are looking forward to the upcoming IMW meeting. IMW is an important myeloma-specific meeting held every two years. Professor Paul G. Richardson will be presenting data from the phase 2 HORIZON study at the … review. Paul G. Richardson , MD, is Professor of Medicine at Harvard Medical School and Clinical Program Leader, Director of Clinical Research at the Jerome Lipper Multiple Myeloma Center Dana-Farber Cancer Institute in Boston, Massachusetts …

Oncopeptides Announces Acceptance of Data for Presentation at International Myeloma Workshop, September 12-15 | Markets Insider | Business Insider | 8/16/2019

… are looking forward to the upcoming IMW meeting. IMW is an important myeloma-specific meeting held every two years. Professor Paul G. Richardson will be presenting data from the phase 2 HORIZON study at the … review. Paul G. Richardson , MD, is Professor of Medicine at Harvard Medical School and Clinical Program Leader, Director of Clinical Research at the Jerome Lipper Multiple Myeloma Center Dana-Farber Cancer Institute in Boston, Massachusetts …

Jakob Lindberg

Oncopeptides Announces Acceptance of Data for Presentation at International Myeloma Workshop, September 12-15 | PR Newswire | 8/17/2019

… of Peptidase Enhanced Cytotoxics (PEnC) and is presently being evaluated in a broad global clinical development program. Comment from CEO Jakob Lindberg “We are looking forward to the upcoming IMW meeting. IMW is an important … review. Paul G. Richardson , MD, is Professor of Medicine at Harvard Medical School and Clinical Program Leader, Director of Clinical Research at the Jerome Lipper Multiple Myeloma Center Dana-Farber Cancer Institute in Boston, Massachusetts …

Oncopeptides Announces Acceptance of Data for Presentation at International Myeloma Workshop, September 12-15 | Markets Insider | Business Insider | 8/16/2019

… of Peptidase Enhanced Cytotoxics (PEnC) and is presently being evaluated in a broad global clinical development program. Comment from CEO Jakob Lindberg “We are looking forward to the upcoming IMW meeting. IMW is an important … review. Paul G. Richardson , MD, is Professor of Medicine at Harvard Medical School and Clinical Program Leader, Director of Clinical Research at the Jerome Lipper Multiple Myeloma Center Dana-Farber Cancer Institute in Boston, Massachusetts …

Zirui Song

Harvard Med: BCBS of Massachusetts’ global payments may slow spending growth | Becker’s Hospital Review | 7/18/2019

… to use more preventive care and cut back on services that are more wasteful. Led by researchers from Boston-based Harvard Medical School, the study examined quality and claims data from BCBS from 2006-16. Researchers … are high, and they continue to grow nationwide,” study author Zirui Song, MD, PhD, assistant professor of healthcare policy and of medicine at Harvard Medical School, said in an article for the university. “The evidence …

New Harvard Medical School Study Finds Blue Cross Blue Shield of Massachusetts Alternative Quality Contract Slowed Spending, Improved Care Over 8 Years | PR Newswire | 7/18/2019

… the rate of medical spending growth by up to 12% while improving patient care over the course of eight years, Harvard Medical School researchers report in a landmark study published today in the New England … the delivery of care over its first 8 years,” said Zirui Song, MD, PhD, assistant professor of health care policy and medicine at Harvard Medical School and Massachusetts General Hospital, and the study’s leading researcher …

David Geffen

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus | BMJ | 8/12/2019

… Center and Faculty of Medicine Carl Gustav Carus, TU Dresden , Dresden , Germany 2 Department of Medicine , Brigham and Women’s Hospital, Harvard Medical School , Boston , Massachusetts , USA 3 University of California at San Francisco and VA … University of Toronto , Toronto , Ontario , Canada 17 Division of Rheumatology, David Geffen School of Medicine , University of California at Los Angeles , Los Angeles , California , USA 18 Department of Rheumatology and Clinical Immunology , Charité – Universitätsmedizin Berlin …

Role of brain imaging in disorders of brain-gut interaction: a Rome Working Team Report | BMJ | 8/7/2019

… Borsook 7 1 G. Oppenheimer Center for Neurobiology of Stress and Resilience, Vatche and Tamar Manoukian Division of Digestive Diseases David Geffen School of Medicine at UCLA , Los Angeles , California , USA 2 Neurogastroenterology Group , Queen … and the Brain, Boston Children’s, Massachusetts General and McLean Hospitals , Harvard Medical School , Boston , Massachusetts , USA Correspondence to Dr Emeran A Mayer; emayer{at}ucla.edu , EMayer{at}mednet.ucla.edu Abstract Imaging of the living human brain …

Tonmoy Sharma

Tonmoy Sharma, Sovereign Health CEO, Discusses Resources on How to Battle Addiction and Mental | PR Newswire | 11/14/2017

SAN CLEMENTE, Calif. , Nov. 14, 2017 /PRNewswire/ – Tonmoy Sharma , M.B.B.S., M.Sc., founder and Chief Executive Officer of Sovereign Health , discusses addiction and mental health in an interview on FOX 31 Denver Colorado’s Best. Dr. Sharma … according to the independent eBASIS report from McLean Hospital, a Harvard Medical School affiliate. In McLean’s quarterly reports for 2016, Sovereign has surpassed 50 other treatment centers nationwide in several important health care measures. Sovereign

Tonmoy Sharma, Sovereign Health CEO, Discusses Resources on How to Battle Addiction and Mental Health in an Interview with FOX 31 Denver | PR Newswire | 11/14/2017

Tonmoy Sharma, Sovereign Health CEO, Discusses Resources on How to Battle Addiction and Mental Health in an Interview with FOX 31 Denver News provided by Nov 14, 2017, 09:00 SAN CLEMENTE, Calif. , Nov. 14, 2017 … according to the independent eBASIS report from McLean Hospital, a Harvard Medical School affiliate. In McLean’s quarterly reports for 2016, Sovereign has surpassed 50 other treatment centers nationwide in several important health care measures. Sovereign

Kamal Jethwani

Partners Connected Health And Hitachi Develop An Explainable AI Technology To Help Doctors Predict Readmissions And Improve Patient Outcomes | PR Newswire | 12/12/2017

… us predict events, but as end-users, we can’t tell why the machine is predicting something a certain way,” said Kamal Jethwani , MD, MPH, Senior Director, Partners Connected Health Innovation. “With this innovation, doctors and … health care entities. Partners is a principal teaching affiliate of Harvard Medical School. About Hitachi, Ltd. Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan , delivers innovations that answer society’s challenges. The company’s consolidated revenues for …

Katherine Baicker

A Decade-Old Experiment To Control Massachusetts’ Health Care Costs Is Actually Paying Off | Kaiser Health News | 7/19/2019

… paying for health care are going be to an important part of the solution to rising health care costs,” said Katherine Baicker, dean of the University of Chicago Harris School of Public Policy. Boston Globe … problems in today’s economy. In a new study, researchers at Harvard Medical School found that a payment plan from Blue Cross Blue Shield of Massachusetts that rewards doctors who control costs is linked to smaller …

Blue Cross’s approach to paying doctors based on quality of care shows results, Harvard study finds - The Boston Globe | 7/18/2019

… a potential strategy to combat one of the most vexing problems in today’s economy. In a new study, researchers at Harvard Medical School found that a payment plan from Blue Cross Blue Shield of Massachusetts … part of the solution to rising health care costs,” said Katherine Baicker, dean of the University of Chicago Harris School of Public Policy, who was not involved in the study. Doctors and hospitals traditionally have …

Robert Langer

Daré Announces Presentation of Two Posters at the 2019 Controlled Release Society Annual Meeting & Exposition | Markets Insider | Business Insider | 7/22/2019

Robert Langer from the Massachusetts Institute of Technology and Dr. William Crowley from Massachusetts General Hospital and Harvard Medical School. Unlike other IVR product designs, Daré’s IVR technology is designed to allow for active drug to be homogenized in a solid EVA polymer matrix that eliminates the need for a membrane or reservoir to contain the active drug or control its release. Individual drug segments provide the opportunity for multiple …